The CBX5 Knockout AGS Polyclonal Cells product consists of a CRISPR/Cas9-edited polyclonal knockout cell population derived from the AGS human gastric adenocarcinoma cell line, engineered to disrupt the CBX5 gene (encoding HP1??). This heterogeneic knockout pool provides a versatile loss-of-function model to investigate epigenetic silencing mechanisms without single-cell cloning artifacts.
The AGS host cell line is a widely utilized model of gastric adenocarcinoma, displaying epithelial morphology and retaining key features of gastric mucosal biology and barrier function. It is extensively employed to study gastric cancer pathogenesis, epithelial-mesenchymal transition, and therapeutic response.
CBX5 (HP1??) is a central component of heterochromatin, recognizing and binding trimethylated lysine 9 of histone H3 (H3K9me3) through its chromodomain, thereby mediating transcriptional repression and chromatin compaction. Upstream methyltransferases such as SUV39H1 and SETDB1 establish the H3K9me3 mark, while Aurora B kinase phosphorylates CBX5, modulating its binding dynamics. CBX5 interacts with multiple factors including SUV39H1, Lamin B receptor, HP1BP3, CAF-1, KAP1/TRIM28, and TRIM28, forming complexes that maintain heterochromatin integrity, chromosome cohesion, and gene silencing. In the signaling network, CBX5 functions downstream of H3K9me3 deposition and acts upstream of heterochromatin domain spreading, lamin-associated chromatin organization, and silencing of repetitive elements and tumor suppressor genes.
In the context of gastric adenocarcinoma, disruption of CBX5-mediated heterochromatin may release transcriptional repression of genes involved in cell proliferation, invasion, and drug resistance. This polyclonal knockout population enables interrogation of epigenetic dysregulation in gastric tumorigenesis, providing insights into how loss of heterochromatin factors contributes to genomic instability and altered gene expression programs characteristic of gastric cancer progression.
Researchers can employ this model for diverse experimental assays including ChIP-qPCR for H3K9me3 profiling, RNA-seq transcriptome analysis, Western blotting for heterochromatin markers, immunofluorescence detection of HP1??, and functional studies such as cell proliferation, colony formation, migration/invasion, and drug sensitivity testing. By comparing knockout and parental AGS cells, scientists can elucidate CBX5-dependent transcriptional programs and evaluate the impact on tumorigenic properties. For further technical details, please contact Ascent Research.
